This page is part of the CH IDMP (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:AdministrableProductDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "PhP-Enfortumabum-vedotinum-30-Solution"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-administrableproductdefinition"^^xsd:anyURI ;
fhir:l <http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-administrableproductdefinition> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition PhP-Enfortumabum-vedotinum-30-Solution</b></p><a name=\"PhP-Enfortumabum-vedotinum-30-Solution\"> </a><a name=\"hcPhP-Enfortumabum-vedotinum-30-Solution\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-administrableproductdefinition.html\">AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Padcev-30mg-Powder.html\">MedicinalProductDefinition: extension = Lyophilisate for solution for infusion; identifier = http://fhir.ch/ig/ch-idmp/sid/mpid#Medical Product Identifier#CH-01100869-0682910040000; indication = Padcev ist indiziert zur Behandlung von Erwachsenen mit lokal fortgeschrittenem oder metastasiertem Urothelkarzinom (mUC), die eine platinhaltige Chemotherapie im neoadjuvanten/adjuvanten, lokal fortgeschrittenen oder metastasierten Setting erhalten haben und die während oder nach der Behandlung mit einem Inhibitor des programmierten Zelltodrezeptors-1 (PD-1) oder des programmierten Zelltod-Liganden 1 (PD-L1) einen Progress oder einen Rückfall der Erkrankung erlitten haben.; legalStatusOfSupply = A: Single dispensing requiring a medical or veterinary prescription; additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Biologics</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{http://standardterms.edqm.eu 11210000}\">Solution for Infusion</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{http://standardterms.edqm.eu 15060000}\">Vial</span></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20045000}\">Intravenous use</span></td></tr></table></div>"^^rdf:XMLLiteral ]
] ; #
fhir:status [ fhir:v "active"] ; #
fhir:formOf ( [
fhir:l fhir:MedicinalProductDefinition/Padcev-30mg-Powder ;
fhir:reference [ fhir:v "MedicinalProductDefinition/Padcev-30mg-Powder" ]
] ) ; #
fhir:administrableDoseForm [
( fhir:coding [
fhir:system [
fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ;
fhir:l <http://standardterms.edqm.eu> ] ;
fhir:code [ fhir:v "11210000" ] ;
fhir:display [ fhir:v "Solution for Infusion" ] ] )
] ; #
fhir:unitOfPresentation [
( fhir:coding [
fhir:system [
fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ;
fhir:l <http://standardterms.edqm.eu> ] ;
fhir:code [ fhir:v "15060000" ] ;
fhir:display [ fhir:v "Vial" ] ] )
] ; #
fhir:routeOfAdministration ( [
fhir:code [
( fhir:coding [
fhir:system [
fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ;
fhir:l <http://standardterms.edqm.eu> ] ;
fhir:code [ fhir:v "20045000" ] ;
fhir:display [ fhir:v "Intravenous use" ] ] ) ]
] ) . #
IG © 2026+ Refdata Foundation. Package ch.fhir.ig.ch-idmp#1.0.0-ballot based on FHIR 5.0.0. Generated 2026-06-12
Links: Table of Contents |
QA Report
| Propose a change